戻る Agenda
Session 2 Track B: Clinical Trials Innovation in Canada
Session Chair(s)
Fiona M Frappier, PhD
Senior Policy Analyst
Health Canada, Canada
Mandy Collier
Director, Health Products and Food Branch
Health Canada, Canada
Clinical trials continue to try new and innovative approaches to improve trial outcomes and patient health, and the need to modernize the way we regulate these trials in Canada has become clear. This session will provide an overview of Health Canada’s approach to modernization of clinical trial regulations, include case studies of how patients have contributed to resource development and describe how decentralized trials have the potential to transform the way we conduct clinical research. The objective of this session is to provide an overview of how industry, government and research organizations are aiming to modernize clinical development.
Learning Objective : At the conclusion of this session, participants should be able to:
- Outline Health Canada’s Clinical Trial Modernization Initiative
- Describe new approaches to decentralized trials
- Address patient considerations in improving clinical trials
Speaker(s)
Health Canada’s Approach to Clinical Trial Modernization
Carole Legare, MD
Health Canada, Canada
Director, Office of Clinical Trials, TPD
Engaging Patients and the Public with Clinical Trials: Two Case Studies to Demonstrate Resources and Tools to Help Your Work
Dawn P. Richards, PhD
Clinical Trials Ontario, Canada
Director, Patient and Public Engagement
Modernizing Clinical Trials through the Global Adoption of Decentralized Clinical Trials
Scott Askin, MSc
Novartis Pharma AG, Switzerland
Global Program Regulatory Director